Purple Biotech (PPBT)
(Real Time Quote from BATS)
$2.15 USD
0.00 (0.00%)
Updated Aug 7, 2025 11:40 AM ET
3-Hold of 5 3
C Value D Growth D Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Purple Biotech Ltd. Sponsored ADR has a market cap of $5.56M, which represents its share price of $2.15 multiplied by its outstanding shares number of 2.59M. As a small-cap company, PPBT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PPBT 2.15 0.00(0.00%)
Will PPBT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PPBT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PPBT
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy
What Makes Purple Biotech (PPBT) a New Buy Stock
PPBT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PPBT
Purple Biotech GAAP EPADS of -$0.57
Purple Biotech Reports Second Quarter 2025 Financial Results | PPBT Stock News
Purple Biotech reports Q2 EPS 40c vs $1.80 last year
Purple Biotech (PPBT) Highlights Scientific Progress and Strategic Goals for 2025 | PPBT Stock News
Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical ...